487. Severity and Clinical Outcomes of Clostridium difficile Infection Based on Toxin B Assay Results

BACKGROUND: Clostridium difficile infection (CDI) remains a major health problem in the United States. The IDSA guidelines recommend using stool toxin assay as part of a multistep algorithm rather than nucleic acid amplification test (NAAT) alone. However, the clinical significance of toxin negative...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Forum Infect Dis
Egile Nagusiak: Kamimoto, Jorge Jo, Susanibar, Sandra, Mohan, Meera, Jenjaroenpun, Piroon, Gayathri, Krishnan, Rico, Juan Carlos, Burgess, Mary J, Tytarenko, Ruslana, Emery, Nicole, Rosenbaum, Eric, Walker, Brian, Nookaew, Intawat, Kothari, Atul
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253691/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.496
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak